BCC Excision Revisited

Completed

• Conditions: Eye Cancer; Eye Diseases; Basal Cell Carcinoma

• Registration Number: NCT05853315
• Lead Sponsor: Medical University of Vienna

Brief Summary

To readdress basal cell carcinoma (BCC) in the periocular region to prove histologically controlled surgical treatment efficacy and to identify high-risk characteristics.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-12
• Primary Completion: 2023-04-01
• Status Verified: 2023-05
• Study Completion: 2023-05-01
• Study First Submitted: 2023-05-02
• Study First Submitted QC: 2023-05-02
• Study First Posted: 2023-05-10
• Last Update Submitted: 2023-05-14
• Last Update Posted: 2023-05-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 451

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BCC Recurrence	mean 3-5 years

Trial Locations

Locations (1)

Medical University of Vienna; 🇦🇹 Vienna, Austria